RIA Advisory Group »

Adma Biologics shares owned by RIA Advisory Group

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by RIA Advisory Group from 13F filings

Historical chart of RIA Advisory Group investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by RIA Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by RIA Advisory Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $98k 11k 9.01

More positions owned by RIA Advisory Group

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr S&p 100 Etf (OEF)
Ishares Silver Tr Ishares Call Option (SLV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Sprott Asset Management Physical Silver (PSLV)
Coca-Cola Company (KO)
Johnson & Johnson (JNJ)
Spdr Series Trust State Street Spd (BIL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
McDonald's Corporation (MCD)
Rbb Fund Trust First Eagle Over (FEOE)

View all positions for RIA Advisory Group

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Westfield Capital Management Company
Capital Research Global Investors
Nuveen
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
UBS Group
Thrivent Financial for Lutherans
Caligan Partners
Susquehanna International

View all funds holding Adma Biologics